Structure

Physi-Chem Properties

Molecular Weight:  548.42
Volume:  624.834
LogP:  8.506
LogD:  5.951
LogS:  -7.106
# Rotatable Bonds:  9
TPSA:  46.53
# H-Bond Aceptor:  3
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.26
Synthetic Accessibility Score:  4.674
Fsp3:  0.703
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.763
MDCK Permeability:  1.0503814337425865e-05
Pgp-inhibitor:  0.991
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.528
30% Bioavailability (F30%):  0.558

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.018
Plasma Protein Binding (PPB):  98.05042266845703%
Volume Distribution (VD):  1.729
Pgp-substrate:  2.0962822437286377%

ADMET: Metabolism

CYP1A2-inhibitor:  0.035
CYP1A2-substrate:  0.342
CYP2C19-inhibitor:  0.181
CYP2C19-substrate:  0.773
CYP2C9-inhibitor:  0.121
CYP2C9-substrate:  0.922
CYP2D6-inhibitor:  0.205
CYP2D6-substrate:  0.537
CYP3A4-inhibitor:  0.528
CYP3A4-substrate:  0.354

ADMET: Excretion

Clearance (CL):  6.068
Half-life (T1/2):  0.009

ADMET: Toxicity

hERG Blockers:  0.241
Human Hepatotoxicity (H-HT):  0.074
Drug-inuced Liver Injury (DILI):  0.036
AMES Toxicity:  0.009
Rat Oral Acute Toxicity:  0.231
Maximum Recommended Daily Dose:  0.977
Skin Sensitization:  0.593
Carcinogencity:  0.033
Eye Corrosion:  0.012
Eye Irritation:  0.529
Respiratory Toxicity:  0.875

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC473220

Natural Product ID:  NPC473220
Common Name*:   (1R,2R,4As,8As,3'e,5'r,1''s)-(+)-1-[6'-(2'',2''-Dimethyl-6''-Methylenecyclohexyl)-4'-Methyl-5'-Benzoyloxyhex-3'-Enyl]-2,5,5,8A-Tetramethyldecahydronaphthalen-2-Ol
IUPAC Name:   [(E,2R)-6-[(1R,2R,4aS,8aS)-2-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-1-[(1S)-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylhex-3-en-2-yl] benzoate
Synonyms:  
Standard InCHIKey:  PUPSZAFUUHIATB-QLPZCOGZSA-N
Standard InCHI:  InChI=1S/C37H56O3/c1-26-16-13-21-34(3,4)29(26)25-30(40-33(38)28-17-10-9-11-18-28)27(2)15-12-19-32-36(7)23-14-22-35(5,6)31(36)20-24-37(32,8)39/h9-11,15,17-18,29-32,39H,1,12-14,16,19-25H2,2-8H3/b27-15+/t29-,30-,31+,32-,36+,37-/m1/s1
SMILES:  C/C(=CCC[C@H]1[C@](C)(O)CC[C@@H]2[C@]1(C)CCCC2(C)C)/[C@@H](C[C@@H]1C(=C)CCCC1(C)C)OC(=O)c1ccccc1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL373793
PubChem CID:   16109741
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33073 physeter macrocephalus Species Physeteridae Eukaryota n.a. n.a. n.a. PMID[17315955]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1183 Cell Line WiDr Homo sapiens ED50 > 10.0 ug ml-1 PMID[468992]
NPT81 Cell Line A549 Homo sapiens ED50 > 10.0 ug ml-1 PMID[468992]
NPT83 Cell Line MCF7 Homo sapiens ED50 > 10.0 ug ml-1 PMID[468992]
NPT27 Others Unspecified ED50 > 10.0 ug ml-1 PMID[468992]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 85.6 % PMID[468992]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC473220 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC470753
0.9916 High Similarity NPC470765
0.9268 High Similarity NPC275576
0.9194 High Similarity NPC169913
0.9141 High Similarity NPC203486
0.9141 High Similarity NPC126516
0.9141 High Similarity NPC329913
0.9141 High Similarity NPC48929
0.8915 High Similarity NPC472656
0.8872 High Similarity NPC224491
0.8828 High Similarity NPC147561
0.8815 High Similarity NPC472569
0.8815 High Similarity NPC25768
0.8815 High Similarity NPC57628
0.8815 High Similarity NPC188865
0.8815 High Similarity NPC475122
0.8815 High Similarity NPC95265
0.8815 High Similarity NPC11685
0.8815 High Similarity NPC95810
0.8815 High Similarity NPC163719
0.8815 High Similarity NPC472570
0.8815 High Similarity NPC70716
0.8815 High Similarity NPC125106
0.8815 High Similarity NPC472573
0.8815 High Similarity NPC476974
0.876 High Similarity NPC470278
0.876 High Similarity NPC72915
0.875 High Similarity NPC472568
0.875 High Similarity NPC473088
0.875 High Similarity NPC171525
0.875 High Similarity NPC174982
0.875 High Similarity NPC470159
0.875 High Similarity NPC472575
0.875 High Similarity NPC29704
0.875 High Similarity NPC472571
0.875 High Similarity NPC476973
0.875 High Similarity NPC184817
0.875 High Similarity NPC470157
0.875 High Similarity NPC469349
0.875 High Similarity NPC177940
0.875 High Similarity NPC472572
0.875 High Similarity NPC471104
0.875 High Similarity NPC70403
0.875 High Similarity NPC158663
0.875 High Similarity NPC200471
0.875 High Similarity NPC472556
0.875 High Similarity NPC96903
0.8741 High Similarity NPC91703
0.8741 High Similarity NPC163087
0.8741 High Similarity NPC477468
0.8739 High Similarity NPC128368
0.8731 High Similarity NPC16912
0.8722 High Similarity NPC214550
0.8722 High Similarity NPC475652
0.8722 High Similarity NPC210591
0.8712 High Similarity NPC472374
0.8712 High Similarity NPC472551
0.8712 High Similarity NPC472545
0.8712 High Similarity NPC472372
0.8689 High Similarity NPC45794
0.8686 High Similarity NPC473602
0.8676 High Similarity NPC241951
0.8676 High Similarity NPC470152
0.8676 High Similarity NPC475759
0.8657 High Similarity NPC473109
0.8657 High Similarity NPC200592
0.8657 High Similarity NPC48017
0.8657 High Similarity NPC90614
0.8657 High Similarity NPC100913
0.8657 High Similarity NPC211137
0.8657 High Similarity NPC4341
0.8657 High Similarity NPC476094
0.8657 High Similarity NPC184747
0.8657 High Similarity NPC275592
0.8657 High Similarity NPC473613
0.8657 High Similarity NPC473112
0.8657 High Similarity NPC473081
0.8657 High Similarity NPC473060
0.8657 High Similarity NPC43241
0.8657 High Similarity NPC473758
0.8657 High Similarity NPC147880
0.8657 High Similarity NPC171207
0.8657 High Similarity NPC473085
0.8657 High Similarity NPC97667
0.8647 High Similarity NPC183122
0.8647 High Similarity NPC39549
0.8647 High Similarity NPC283375
0.8647 High Similarity NPC475373
0.8636 High Similarity NPC477893
0.8636 High Similarity NPC477896
0.8629 High Similarity NPC473243
0.8623 High Similarity NPC281717
0.8594 High Similarity NPC190849
0.8594 High Similarity NPC171007
0.8593 High Similarity NPC97947
0.8593 High Similarity NPC291599
0.8593 High Similarity NPC41481
0.8593 High Similarity NPC472576
0.8593 High Similarity NPC87448
0.8593 High Similarity NPC118080
0.8593 High Similarity NPC27377
0.8571 High Similarity NPC477874
0.8571 High Similarity NPC173569
0.8561 High Similarity NPC270590
0.8561 High Similarity NPC474608
0.8561 High Similarity NPC471101
0.8561 High Similarity NPC473215
0.8561 High Similarity NPC266265
0.8561 High Similarity NPC476975
0.8561 High Similarity NPC92293
0.8561 High Similarity NPC301556
0.8551 High Similarity NPC474935
0.8529 High Similarity NPC472546
0.8529 High Similarity NPC34012
0.8519 High Similarity NPC472547
0.8507 High Similarity NPC249817
0.85 High Similarity NPC112216
0.85 High Similarity NPC470245
0.85 High Similarity NPC7095
0.85 High Similarity NPC473214
0.8496 Intermediate Similarity NPC195647
0.8496 Intermediate Similarity NPC472577
0.8496 Intermediate Similarity NPC66761
0.8496 Intermediate Similarity NPC291638
0.8496 Intermediate Similarity NPC17877
0.8467 Intermediate Similarity NPC191082
0.8467 Intermediate Similarity NPC475429
0.8467 Intermediate Similarity NPC139067
0.8467 Intermediate Similarity NPC177340
0.8467 Intermediate Similarity NPC473673
0.8467 Intermediate Similarity NPC270498
0.8467 Intermediate Similarity NPC477894
0.8467 Intermediate Similarity NPC147217
0.8467 Intermediate Similarity NPC246480
0.8456 Intermediate Similarity NPC266374
0.8444 Intermediate Similarity NPC216940
0.8444 Intermediate Similarity NPC472371
0.8444 Intermediate Similarity NPC22676
0.8444 Intermediate Similarity NPC198621
0.8444 Intermediate Similarity NPC472395
0.8444 Intermediate Similarity NPC475482
0.8443 Intermediate Similarity NPC221275
0.844 Intermediate Similarity NPC470153
0.8429 Intermediate Similarity NPC60509
0.8429 Intermediate Similarity NPC250046
0.8429 Intermediate Similarity NPC81698
0.8413 Intermediate Similarity NPC50872
0.8409 Intermediate Similarity NPC472394
0.8406 Intermediate Similarity NPC470231
0.8406 Intermediate Similarity NPC51314
0.8406 Intermediate Similarity NPC67777
0.8397 Intermediate Similarity NPC475138
0.8394 Intermediate Similarity NPC172311
0.8385 Intermediate Similarity NPC51448
0.8385 Intermediate Similarity NPC115797
0.8382 Intermediate Similarity NPC248287
0.8382 Intermediate Similarity NPC234548
0.838 Intermediate Similarity NPC477905
0.8369 Intermediate Similarity NPC198455
0.8369 Intermediate Similarity NPC477483
0.8369 Intermediate Similarity NPC325032
0.8369 Intermediate Similarity NPC165260
0.8369 Intermediate Similarity NPC31829
0.8369 Intermediate Similarity NPC161239
0.8358 Intermediate Similarity NPC473399
0.8358 Intermediate Similarity NPC473216
0.8345 Intermediate Similarity NPC127857
0.8322 Intermediate Similarity NPC256142
0.8322 Intermediate Similarity NPC472005
0.8322 Intermediate Similarity NPC1173
0.8322 Intermediate Similarity NPC304876
0.8322 Intermediate Similarity NPC473414
0.8322 Intermediate Similarity NPC249471
0.8322 Intermediate Similarity NPC472022
0.8322 Intermediate Similarity NPC158333
0.8322 Intermediate Similarity NPC472657
0.8322 Intermediate Similarity NPC265395
0.8322 Intermediate Similarity NPC472658
0.8322 Intermediate Similarity NPC472030
0.8322 Intermediate Similarity NPC237549
0.8322 Intermediate Similarity NPC242262
0.8322 Intermediate Similarity NPC257213
0.8322 Intermediate Similarity NPC77719
0.831 Intermediate Similarity NPC279442
0.8308 Intermediate Similarity NPC253681
0.8295 Intermediate Similarity NPC295664
0.8293 Intermediate Similarity NPC186933
0.8286 Intermediate Similarity NPC48599
0.8286 Intermediate Similarity NPC209592
0.8286 Intermediate Similarity NPC475552
0.8273 Intermediate Similarity NPC38696
0.8271 Intermediate Similarity NPC238370
0.8264 Intermediate Similarity NPC282239
0.8264 Intermediate Similarity NPC112523
0.8264 Intermediate Similarity NPC228204
0.8264 Intermediate Similarity NPC26033
0.8264 Intermediate Similarity NPC114410
0.8261 Intermediate Similarity NPC472801
0.8261 Intermediate Similarity NPC304110
0.8261 Intermediate Similarity NPC192658

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC473220 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8538 High Similarity NPD7008 Discontinued
0.8478 Intermediate Similarity NPD7236 Approved
0.8258 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.8182 Intermediate Similarity NPD7239 Suspended
0.8145 Intermediate Similarity NPD5951 Approved
0.8042 Intermediate Similarity NPD6273 Approved
0.8 Intermediate Similarity NPD7961 Discontinued
0.7967 Intermediate Similarity NPD2181 Clinical (unspecified phase)
0.7943 Intermediate Similarity NPD8166 Discontinued
0.7943 Intermediate Similarity NPD7003 Approved
0.7907 Intermediate Similarity NPD7163 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD2629 Approved
0.7857 Intermediate Similarity NPD7702 Clinical (unspecified phase)
0.7812 Intermediate Similarity NPD7610 Discontinued
0.7805 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.7795 Intermediate Similarity NPD4198 Discontinued
0.7769 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.771 Intermediate Similarity NPD7457 Clinical (unspecified phase)
0.7698 Intermediate Similarity NPD7094 Approved
0.7698 Intermediate Similarity NPD6858 Approved
0.7682 Intermediate Similarity NPD7057 Phase 3
0.7682 Intermediate Similarity NPD7058 Phase 2
0.7661 Intermediate Similarity NPD2182 Approved
0.7635 Intermediate Similarity NPD7458 Discontinued
0.7609 Intermediate Similarity NPD6663 Approved
0.7583 Intermediate Similarity NPD1238 Approved
0.7574 Intermediate Similarity NPD5736 Approved
0.7541 Intermediate Similarity NPD1929 Approved
0.7541 Intermediate Similarity NPD1931 Clinical (unspecified phase)
0.7541 Intermediate Similarity NPD1930 Approved
0.7519 Intermediate Similarity NPD6287 Discontinued
0.7482 Intermediate Similarity NPD7713 Phase 3
0.7468 Intermediate Similarity NPD7799 Discontinued
0.7438 Intermediate Similarity NPD2066 Phase 3
0.741 Intermediate Similarity NPD3764 Approved
0.74 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD8127 Discontinued
0.7357 Intermediate Similarity NPD8032 Phase 2
0.7357 Intermediate Similarity NPD7715 Approved
0.7357 Intermediate Similarity NPD7714 Approved
0.7348 Intermediate Similarity NPD7741 Discontinued
0.7344 Intermediate Similarity NPD1609 Clinical (unspecified phase)
0.7339 Intermediate Similarity NPD164 Approved
0.7339 Intermediate Similarity NPD5909 Discontinued
0.7329 Intermediate Similarity NPD4628 Phase 3
0.7312 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.7266 Intermediate Similarity NPD4141 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD2346 Discontinued
0.7226 Intermediate Similarity NPD1283 Approved
0.7222 Intermediate Similarity NPD2799 Discontinued
0.72 Intermediate Similarity NPD1237 Approved
0.7183 Intermediate Similarity NPD4140 Approved
0.7172 Intermediate Similarity NPD5408 Approved
0.7172 Intermediate Similarity NPD5406 Approved
0.7172 Intermediate Similarity NPD5404 Approved
0.7172 Intermediate Similarity NPD5405 Approved
0.7143 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7122 Intermediate Similarity NPD2798 Approved
0.712 Intermediate Similarity NPD6647 Phase 2
0.7115 Intermediate Similarity NPD7768 Phase 2
0.7111 Intermediate Similarity NPD3019 Approved
0.7099 Intermediate Similarity NPD6010 Discontinued
0.7097 Intermediate Similarity NPD7819 Suspended
0.7095 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.709 Intermediate Similarity NPD9545 Approved
0.709 Intermediate Similarity NPD7009 Phase 2
0.7083 Intermediate Similarity NPD3528 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD1088 Approved
0.708 Intermediate Similarity NPD3972 Approved
0.7073 Intermediate Similarity NPD8368 Discontinued
0.7066 Intermediate Similarity NPD8424 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD2935 Discontinued
0.705 Intermediate Similarity NPD2797 Approved
0.7049 Intermediate Similarity NPD1989 Approved
0.7045 Intermediate Similarity NPD690 Clinical (unspecified phase)
0.7042 Intermediate Similarity NPD2313 Discontinued
0.704 Intermediate Similarity NPD1932 Approved
0.7034 Intermediate Similarity NPD7097 Phase 1
0.702 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD7997 Clinical (unspecified phase)
0.7014 Intermediate Similarity NPD6355 Discontinued
0.7007 Intermediate Similarity NPD4807 Approved
0.7007 Intermediate Similarity NPD4806 Approved
0.7007 Intermediate Similarity NPD1281 Approved
0.6986 Remote Similarity NPD4308 Phase 3
0.6985 Remote Similarity NPD5306 Approved
0.6985 Remote Similarity NPD2932 Approved
0.6985 Remote Similarity NPD5305 Approved
0.6982 Remote Similarity NPD8361 Approved
0.6982 Remote Similarity NPD8360 Approved
0.6982 Remote Similarity NPD8435 Approved
0.6977 Remote Similarity NPD2329 Discontinued
0.6972 Remote Similarity NPD7095 Approved
0.6957 Remote Similarity NPD4878 Approved
0.6948 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6946 Remote Similarity NPD8407 Phase 2
0.6944 Remote Similarity NPD2979 Phase 3
0.694 Remote Similarity NPD9493 Approved
0.6923 Remote Similarity NPD6798 Discontinued
0.6917 Remote Similarity NPD1086 Approved
0.6917 Remote Similarity NPD1090 Approved
0.6917 Remote Similarity NPD9256 Approved
0.6917 Remote Similarity NPD9258 Approved
0.6917 Remote Similarity NPD1089 Approved
0.6912 Remote Similarity NPD5691 Approved
0.6901 Remote Similarity NPD6832 Phase 2
0.6885 Remote Similarity NPD1202 Approved
0.6885 Remote Similarity NPD5122 Clinical (unspecified phase)
0.6884 Remote Similarity NPD1201 Approved
0.688 Remote Similarity NPD7798 Approved
0.6879 Remote Similarity NPD5740 Clinical (unspecified phase)
0.6879 Remote Similarity NPD6085 Phase 2
0.6871 Remote Similarity NPD7305 Phase 1
0.6867 Remote Similarity NPD4110 Phase 3
0.6867 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6867 Remote Similarity NPD3750 Approved
0.6864 Remote Similarity NPD8434 Phase 2
0.6861 Remote Similarity NPD4626 Approved
0.6857 Remote Similarity NPD1876 Approved
0.6857 Remote Similarity NPD2199 Approved
0.6857 Remote Similarity NPD5667 Approved
0.6857 Remote Similarity NPD2198 Approved
0.6855 Remote Similarity NPD3495 Discontinued
0.6853 Remote Similarity NPD6966 Discovery
0.6853 Remote Similarity NPD6039 Approved
0.6842 Remote Similarity NPD4869 Clinical (unspecified phase)
0.6839 Remote Similarity NPD3226 Approved
0.6839 Remote Similarity NPD8485 Approved
0.6835 Remote Similarity NPD1608 Approved
0.6835 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6833 Remote Similarity NPD800 Approved
0.6829 Remote Similarity NPD688 Clinical (unspecified phase)
0.6829 Remote Similarity NPD1693 Approved
0.6828 Remote Similarity NPD4307 Phase 2
0.6824 Remote Similarity NPD4476 Approved
0.6824 Remote Similarity NPD4477 Approved
0.6824 Remote Similarity NPD2438 Suspended
0.6812 Remote Similarity NPD3026 Approved
0.6812 Remote Similarity NPD4136 Approved
0.6812 Remote Similarity NPD3023 Approved
0.6812 Remote Similarity NPD4106 Approved
0.6812 Remote Similarity NPD4135 Approved
0.6809 Remote Similarity NPD1470 Approved
0.6806 Remote Similarity NPD3268 Approved
0.68 Remote Similarity NPD9495 Approved
0.6794 Remote Similarity NPD2067 Discontinued
0.6788 Remote Similarity NPD5844 Phase 1
0.6788 Remote Similarity NPD5585 Approved
0.6788 Remote Similarity NPD3024 Approved
0.6788 Remote Similarity NPD3025 Approved
0.6788 Remote Similarity NPD4196 Clinical (unspecified phase)
0.6786 Remote Similarity NPD5327 Phase 3
0.6786 Remote Similarity NPD8313 Approved
0.6786 Remote Similarity NPD8312 Approved
0.6783 Remote Similarity NPD7055 Discontinued
0.6772 Remote Similarity NPD5761 Phase 2
0.6772 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6772 Remote Similarity NPD5760 Phase 2
0.6765 Remote Similarity NPD8150 Discontinued
0.6763 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6757 Remote Similarity NPD3748 Approved
0.6752 Remote Similarity NPD6677 Suspended
0.6752 Remote Similarity NPD7411 Suspended
0.675 Remote Similarity NPD8005 Clinical (unspecified phase)
0.6748 Remote Similarity NPD7748 Approved
0.6739 Remote Similarity NPD1778 Approved
0.6735 Remote Similarity NPD6353 Approved
0.673 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6727 Remote Similarity NPD7177 Discontinued
0.6723 Remote Similarity NPD8486 Clinical (unspecified phase)
0.6723 Remote Similarity NPD9257 Approved
0.6723 Remote Similarity NPD9259 Approved
0.6721 Remote Similarity NPD1239 Approved
0.672 Remote Similarity NPD1564 Approved
0.672 Remote Similarity NPD1565 Approved
0.672 Remote Similarity NPD1566 Phase 3
0.6715 Remote Similarity NPD1894 Discontinued
0.6715 Remote Similarity NPD3091 Approved
0.6714 Remote Similarity NPD6637 Approved
0.6712 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6712 Remote Similarity NPD5121 Approved
0.6712 Remote Similarity NPD5120 Approved
0.6712 Remote Similarity NPD5119 Approved
0.6711 Remote Similarity NPD6099 Approved
0.6711 Remote Similarity NPD2531 Phase 2
0.6711 Remote Similarity NPD6100 Approved
0.671 Remote Similarity NPD7427 Discontinued
0.6707 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6706 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6705 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6691 Remote Similarity NPD4879 Approved
0.669 Remote Similarity NPD1164 Approved
0.6688 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6688 Remote Similarity NPD6599 Discontinued
0.6688 Remote Similarity NPD7028 Phase 2
0.6686 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4102 Approved
0.6667 Remote Similarity NPD5157 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data